Top Featured Companies Dominating the Mammalian Cell Fermentation Technology Landscape
- Shanghai Henlius Biotech, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Evonik
- Thermo Fisher Scientific Inc.
- General Electric
- Danaher Corporation
- Merck KGaA
- Sartorius AG
- Amgen, Inc.
- Eppendorf AG
- Pall Corporation
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In the year 2025, the industry size of mammalian cell fermentation technology is assessed at USD 49.76 billion.
Mammalian Cell Fermentation Technology Market size was valued at USD 46.52 billion in 2024 and is likely to cross USD 137.6 billion by the end of 2037, expanding at more than 8.7% CAGR during the forecast period i.e., between 2025-2037. The market growth is owing to growth in making of personalized medications, advancement in technology for mammalian cell fermentation, and rising chronic disease.
North America industry is set to dominate majority revenue share of 35% by 2037, due to rising investment in biotechnology in the region.
The major players in the market are Shanghai Henlius Biotech, Inc., Evonik, Thermo Fisher Scientific Inc., General Electric, and others.
